EMJ GOLD

The PARTNERS trial has launched in the DRC as the country continues to battle an outbreak that has already led to more than 1,400 cases.

A new analysis is unequivocal in its criticism of the deal, while government officials have robustly defended its funding and value.

Discover the top pharma stories, from ovarian cancer and Ebola vaccines to the biotech M&A rebound.

Novo’s FDA-approved semaglutide injection and pill are now available through the Medicare GLP-1 Bridge.

Flamingo Pharma UK Ltd has notified the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect patient information leaflet.

A joint warning has been issued against promoting newly licensed prescription-only and unlicensed medicines for weight management.

UNICEF and Gavi have made a call to manufacturers to accelerate access to a Bundibugyo vaccine, amid the ongoing Ebola outbreak in the Democratic Republic of the Congo and Uganda.

Australia has committed more than $113m to strengthen preparedness and response, following detection of bird flu in two states.